Mariusz L. Hartman

Dissecting Mechanisms of Melanoma Resistance to BRAF and MEK Inhibitors Revealed Genetic and Non-Genetic Patient- and Drug-Specific Alterations and Remarkable Phenotypic Plasticity

Mariusz L. Hartman, Małgorzata Sztiller-Sikorska, Anna Gajos-Michniewicz · Cells · 2020 · 59 citations · Full text

Medicine, Genetics, Oncology +17

Natural Compounds' Activity against Cancer Stem-Like or Fast-Cycling Melanoma Cells

Małgorzata Sztiller-Sikorska, Kamila Koprowska, Kinga Majchrzak et al. · PLoS ONE · 2014 · 53 citations · Full text

Medicine, Oncology, Pharmacology +17

Gene Expression Profiling Identifies Microphthalmia-Associated Transcription Factor (MITF) and Dickkopf-1 (DKK1) as Regulators of Microenvironment-Driven Alterations in Melanoma Phenotype

Mariusz L. Hartman, Beata Talar, Muhammad Zaeem Noman et al. · PLoS ONE · 2014 · 33 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Vemurafenib and trametinib reduce expression of CTGF and IL-8 in V600EBRAF melanoma cells

Mariusz L. Hartman, Michał Różański, Marta Osrodek et al. · Laboratory Investigation · 2017 · 32 citations · Full text

Life Sciences, Cell Biology, Oncology +12

Plasticity of Drug-Naïve and Vemurafenib- or Trametinib-Resistant Melanoma Cells in Execution of Differentiation/Pigmentation Program

Małgorzata Sztiller-Sikorska, Anna Gajos-Michniewicz, Marta Osrodek et al. · Journal of Oncology · 2019 · 32 citations · Full text

Medicine, Cancer Biology, Oncology +16